SCHEMBL5284067

SCHEMBL5284067

CC(C)=NN=c1scc(-c2ccc(C)cc2)n1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
TDP1 Q9NUW8 2/20 0.42
TP53 P04637 1/20 0.42
PTGS2 P35354 2/20 0.38
ALOX5 P09917 1/20 0.38
IDO1 P14902 2/20 0.37
CA12 O43570 3/20 0.36
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA9 Q16790 3/20 0.36
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
ALOX12 P18054 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5278421 0.87 MAPT (0.39) MAPTSMN1; SMN2TDP1TP53PTGS2
SCHEMBL5278424 0.87 MAPT (0.39) MAPTSMN1; SMN2TDP1TP53PTGS2
SCHEMBL5280481 0.87 SMN1; SMN2 (0.40) MAPTSMN1; SMN2TDP1TP53PTGS2
SCHEMBL5283764 0.86 SMN1; SMN2 (0.43) MAPTSMN1; SMN2TDP1TP53PTGS2
SCHEMBL5287532 0.84 MAPT (0.49) MAPTSMN1; SMN2TDP1PTGS2IDO1
SCHEMBL5284373 0.81 MAPT (0.43) MAPTSMN1; SMN2TDP1PTGS2ALOX5
SCHEMBL5287384 0.81 SMN1; SMN2 (0.49) MAPTSMN1; SMN2TDP1IDO1ALDH1A1
SCHEMBL5287377 0.81 SMN1; SMN2 (0.49) MAPTSMN1; SMN2TDP1IDO1ALDH1A1
SCHEMBL5288480 0.79 MAOA (0.41) MAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL5288475 0.79 MAOA (0.41) MAPTSMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP claimed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US claimed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP claimed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO claimed
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT MAPT 1807/4885SMN1; SMN2 3523/4885TDP1 4136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.